Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

R&D Systems™ Recombinant Human CRACC/SLAMF7 Fc Chimera Protein

Catalog No. 1906SF050
Click to view available options
Quantity:
50 μg
This item is not returnable. View return policy
This item is not returnable. View return policy

The Recombinant Human CRACC/SLAMF7 Fc Chimera Protein is derived from HEK293

  • Recombinant Protein
  • Carrier Free (CF)
  • The carrier free version does not contain Bovine Serum Albumin (BSA)

Specifications

Accession Number Q9NQ25
For Use With (Application) Bioactivity
Gene ID (Entrez) 57823
Molecular Weight (g/mol) 49 kDa
Purification Method >95%, by SDS-PAGE visualized with Silver Staining and quantitative densitometry by Coomassie™ Blue Staining
Quantity 50 μg
Source

Human embryonic kidney cell, HEK293-derived human CRACC/SLAMF7 protein

Human SLAMF7 (Ser23-Met226) Accession # Q9NQ25IEGRMDHuman IgG1 (Pro100-Lys330)N-terminus C-terminus

Storage Requirements Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70°C as supplied. 1 month, 2 to 8°C under sterile conditions after reconstitution. 3 months, ≤ -20°C under sterile conditions after reconstitution.
Endotoxin Concentration <0.10 EU per 1 μg of the protein by the LAL method
Conjugate Unconjugated
Reconstitution Reconstitute at 100 μg/mL in PBS
Buffer Lyophilized from a 0.2 μm filtered solution in PBS
Show More Show Less
Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Your feedback has been submitted: Thank you for helping us improve our website.